Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination

Vaccine

Volumn 15, Issue 14, 1997, Pages 1538-1544

  Böttiger, Mareareta ^a   Forsgren, Marianne ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Long term follow up; Rubella immunization 2 dose; Rubella vaccination surveillance; Sweden

Indexed keywords

RUBELLA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; SWEDEN; VACCINATION;

EID: 0343145716     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00068-6     Document Type: Article

References (23)

1. Christenson, B., Böttiger, M. and Heller, L. Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: First experience. British Medical Journal 1983, 287, 389-391.
2. Böttiger, M. and Heller, L. Experiences from vaccination and revaccination of teenage girls with three different rubella vaccines. Journal of Biological Standardization 1976, 4, 107-114.
3. Christenson, B. and Böttiger, M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994, 12, 41-45.
4. Böttiger, M., Christenson, B., Romanus, V., Taranger, J. and Strandell, A. Swedish experience of a two-dose vaccination programme aiming at eliminating measles, mumps and rubella. British Medical Journal 1987, 295, 1264-1267.
5. Christenson, B. and Böttiger, M. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two dose schedule. Vaccine 1990, 9, 326-329.
6. Strannegård, Ö., Grillner, L. and Lindberg, J.-M. Hemolysis-in-gel test, the demonstration of antibodies to rubella virus. Journal of Clinical Microbiology 1975, 1, 491-494.
7. Forsgren, M. Standardization of techniques and reagents for the study of rubella antibody. Review of Infectious Diseases 1985, 7, (Suppl. 1), 129-134.
8. Böttiger, M. Vaccination not rubella. Läkartidningen (in Swedish) 1979, 76, 3516-3518.
9. Romanus, V., Vaccinationsstatistik från skolorna. Elevvård och hälsa 1995/96, 2, 22. (In Swedish).
10. Taranger, J. and Holmberg, K. Angeläget införa en rikstäckande och systematisk ut-värdering av vaccinbiverkningar. Läkartidningen (in Swedish) 1992, 89, 1691-1693.
11. Grillner, L., Forsgren, M., Barr, B., Böttiger, M., Danielsson, L. and de Verdier, C. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scandinavian Journal of Infectious Diseases 1983, 15, 321-325.
12. Barr, B., Rubellaembryopati. Wellcome Symposium on Rubella Vaccination, Stockholm (in Swedish), 1975, pp. 11-21.
13. Rabo, E. and Taranger, J. Scandinavian model for eliminating measles, mumps and rubella. British Medical Journal 1984, 289, 1402-1404.
14. Peltola, H., Heinonen, O.P., Valle, M., Paunio, M., Virtanen, M., Karanko, V. and Cantell, K. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. New England Journal of Medicine 1994, 331, 1397-1402.
15. Ukkonen, P. Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1982. Scandinavian Journal of Infectious Diseases 1996, 28, 31-35.
16. Miller, E., Tookey, P., Morgan-Capner, P., Hesketh, L., Brown, P., Waight, P., Vurdien, J., Jones, G. and Peckham, C. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Communicable Disease Report 1994, 4, R146-R152.
17. Rubella and congenital rubella syndrome - United States, 1 January 1991 - 7 May 1994. Morbidity and Mortality Weekly Report 1994, 43, 391-401.
18. Horstmann, D.M., Schluederberg, A., Emmons, J.E., Evans, B.K., Randolph, M.F. and Andiman, W.A. Persistence of vaccine-induced immune responses to rubella: Comparison with natural infection. Review of Infectious Diseases 1985, 7, (Suppl.), 80-85.
19. Forsgren, M. and Sörén, L. Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the foetus. Scandinavian Journal of Infectious Diseases 1985, 17, 337-341.
20. Morgan-Capner, P., Hodgson, J., Hambling, M.H., Dulake, C., Coleman, T.J., Boswell, P.A., Booth, J. and Best, J.M. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet 1985, 1, 244-246.
21. Best, J.M., Banatvala, J.E., Morgan-Capner, P. and Miller, E. Foetal infection after maternal reinfection with rubella. Criteria for defining reinfection. British Medical Journal 1989, 299, 773-775.
22. Condon, R. and Bower, C. Two cases of congenital rubella syndrome after previous maternal immunisation. Communicable Disease Intelligence 1991, 15, 465-467.
23. Best, J.M. Rubella vaccines: past, present and future. Epidemiology of Infection 1991, 107, 17-30.